Published on 22/01/2020 3:15:59 PM | Source: Dion Global Solutions Ltd

Alembic Pharmaceutic Q3 net profit jumps 66.91% at Rs 231.19 cr

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel 

Download Telegram App before Joining the Channel

The company reported standalone net profit of Rs 231.19 crore for the quarter ended December 31, 2019 as compared to Rs 138.51 crore in the same period last year, registering a year-on-year growth of 66.91 per cent. Net revenue of the company rose moderately by 16.32 per cent at Rs 1,052.36 crore in October-December quarter of this fiscal as against Rs 904.72 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 4.51 per cent to Rs 731.25 crore from Rs 699.67 crore in year ago period. Other Income dipped by 91.37 per cent at Rs 0.29 crore versus (Dec'18 Rs 3.36 crore).

Operating Profit surged by 56.60 per cent to Rs 321.11 crore as against Rs 205.05 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 34.64 per cent in December quarter. Interest grew by 50.00 per cent y-o-y to Rs 6.93 crore, while Taxation increased by 26.47 per cent at Rs 48.97 crore (Dec'18 Rs 38.72 crore).